SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
GLOBAL HEALTH IMPACT: A BASIS FOR LABELING AND LICENSING CAMPAIGNS?
16 references·1 citing·38 second hop
GLOBAL HEALTH IMPACT: A BASIS FOR LABELING AND LICENSING CAMPAIGNS? (2012)GLOBAL HEALTH IMPACT: A BASIS FOR LABELIN…Comment: Compulsory Licensing of Patented Pharmaceutical Inventions: Evaluating the Options (2009)Comment: Compulsory Licensing…An Economic Justification for Open Access to Essential Medicine Patents in Developing Countries (2009)An Economic Justification for…Fairness in trade II: export subsidies and the Fair Trade movement (2008)Fairness in trade II: export …Access to Medicines (2008)Access to Medicines“Trust Me”: Patent Offices in Developing Countries (2008)“Trust Me”: Patent Offices in…Advance market commitments for vaccines against neglected diseases: estimating costs and effectiveness (2006)Advance market commitments fo…Strong Medicine: Creating Incentives for Pharmaceutical Research on Neglected Diseases (2005)Strong Medicine: Creating Inc…Methods for the Economic Evaluation of Health Care Programmes (2005)Methods for the Economic Eval…A New Trade Framework for Global Healthcare R&D (2004)A New Trade Framework for Glo…The price of innovation: new estimates of drug development costs (2003)The price of innovation: new …Private power, public law the globalization of intellectual property rights (2003)Private power, public law the…Global Health and the Scientific Research Agenda (2003)Global Health and the Scienti…Differential Pricing for Pharmaceuticals: Reconciling Access, R&D and Patents (2003)Differential Pricing for Phar…Global Intellectual Property Rights: Knowledge Access and Development (2002)Global Intellectual Property …Perfecting Patent Prizes (2001)Perfecting Patent PrizesDrugs for neglected diseases: a failure of the market and a public health failure? (2001)Drugs for neglected diseases:…The state of global health in a radically unequal world: patterns and prospects (2011)The state of global health in…Agreement on trade-related aspects of intellectual property rights (2000)Information Feudalism: Who Owns the Knowledge Economy? (2003)Twenty-five years since TRIPS: Patent policy and international business (2020)The COVID-19 Innovation System (2021)Mitigation Pathways Compatible with Long-term Goals (2023)Can Patents Deter Innovation? The Anticommons in Biomedical Research (1998)Access to Essential Drugs in Poor Countries (1999)The Pharmaceutical Commons (2014)Market Failures and Market Framings: Can a market be transformed from the inside? (2017)Stocks for the Long Run (1994)World Development Indicators 2005 (2005)Policies and Incentives for Promoting Innovation in Antibiotic Research (2010)Innovation Inducement Prizes: Connecting Research to Policy (2012)Orphan drugs policies: a suitable case for treatment (2014)Income Inequality in the United States, 1913-1998 (2003)What Counts as Evidence of Educational Achievement? The Role of Constructs in the Pursuit of Equity in Assessment (2010)The Human Right to Health (2011)Globalization and Its Discontents (2015)Famine, Affluence, and Morality (2018)A Contribution to the Theory of Taxation (1927)A Theory of Incentives in Procurement and Regulation (1993)Good Research Practices for Measuring Drug Costs in Cost-Effectiveness Analyses: A Societal Perspective: The ISPOR Drug Cost Task Force Report—Part II (2009)Investments in Pharmaceuticals Before and After TRIPS (2011)How Can Pricing and Reimbursement Policies Improve Affordable Access to Medicines? Lessons Learned from European Countries (2017)Demythologizing the high costs of pharmaceutical research (2011)A systematic review and critical assessment of incentive strategies for discovery and development of novel antibiotics (2015)The estimation of a preference-based measure of health from the SF-36 (2002)Systematic reviews: CRD's guidance for undertaking reviews in health care (2010)Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses (2016)Justice and the Human Development Approach to International Research (2005)John Dewey’s Logic of Science (2012)Toward a New Common Sense (2021)Can the pharmaceutical industry reduce attrition rates? (2004)Clinical development success rates for investigational drugs (2014)Innovation in the pharmaceutical industry: New estimates of R&D costs (2016)Power in global governance (2004)The Politics of International Regime Complexity (2009)The political origins of health inequity: prospects for change (2014)
this work references cited by second hop

References

  • 2005Methods for the Economic Evaluation of Health Care Programmes13,647 cited
  • 2003The price of innovation: new estimates of drug development costs4,264 cited
  • 2003Private power, public law the globalization of intellectual property rights565 cited
  • 2003Differential Pricing for Pharmaceuticals: Reconciling Access, R&D and Patents317 cited
  • 2005Strong Medicine: Creating Incentives for Pharmaceutical Research on Neglected Diseases237 cited
  • 2001Drugs for neglected diseases: a failure of the market and a public health failure?228 cited
  • 2003Global Health and the Scientific Research Agenda137 cited
  • 2006Advance market commitments for vaccines against neglected diseases: estimating costs and effectiveness120 cited
  • 2008Access to Medicines120 cited
  • 2009Comment: Compulsory Licensing of Patented Pharmaceutical Inventions: Evaluating the Options109 cited
  • 2004A New Trade Framework for Global Healthcare R&D109 cited
  • 2009An Economic Justification for Open Access to Essential Medicine Patents in Developing Countries106 cited
  • 2002Global Intellectual Property Rights: Knowledge Access and Development89 cited
  • 2008Fairness in trade II: export subsidies and the Fair Trade movement88 cited
  • 2001

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

Perfecting Patent Prizes
83 cited
  • 2008“Trust Me”: Patent Offices in Developing Countries53 cited
  • Cited by

    • 2011The state of global health in a radically unequal world: patterns and prospects17 cited